FOI/25/254
Read more about this page below
| Reference | FOI/25/254 |
|---|---|
| Description | Semaglutide |
| Date requested | 06/11/2024 |
| Attachments | N/A |
Request
- The number of people who have attended A&E and given Semaglutide as a reason for their visit, where there drug was indicated for weight management - in every year between 2022 and 2024. Please give a figure for each year. Semaglutide also goes under brand names such as Ozempic, Saxenda, Rybelsus and Wegovy – can you please include these names in your records also.
- Please break the figures down to give details of the complications patients presented with as a result of their use of Semaglutide.
Response
Having completed enquiries within the Trust and in respect of Section 1(1)(a), CLCH confirm it does not have a A&E department.